Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Post by retiredcfon Dec 19, 2016 8:02am
328 Views
Post# 25618161

James Hodgins

James HodginsIs scheduled to be on Market Call Tonight on Thursday. It will be interesting to get his take on things given that he recently made MSL his top pick in a Globe & Mail article, not to mention, when he was last on BNN two months ago.  GLTA

MSL-T 2016-10-20 TOP PICK James Hodgins
 
They did not take on all the debt of some others.  It is in Europe.  When US drugs come off patent, it is a patent cliff.  In Europe it is different.  It tends to be about 30-40% because it is more highly regulated to begin with.  Their earnings are more stable.  He likes the management team who have been buying stock recently.  They changed from just buying legacy drugs to buying growth drugs.  He thinks this growth strategy will cause a re-rating of the stock.
 
Login to show your approval   Login to show your disapproval / Be the first to comment
Price:
$1.260
Subject:
MARKET NEUTRAL INVESTING: SMALL/MID-CAP
Bias:
NEUTRAL
Owned:
Yes


<< Previous
Bullboard Posts
Next >>